Type 1 diabetes is an incurable autoimmune disease that strikes randomly and independently of personal lifestyle. 34,560 Danes and 50,000 Swedes are affected by the… Read More »Inside Medicon Valley

With several preventive drugs on the way, teplizumab already approved in the US, and pre-stage 1 type 1 diabetes on the agenda to receive ICD-10… Read More »DiaUnion PIs Daniel Agardh, Flemming Pociot and co-investigator Markus Lundgren presented at ISPAD

Åke Lernmark was part of the group that founded DiaUnion. Last week at EASD he was awarded the Claude Bernard Prize 2023. This is the… Read More »Åke Lernmark receives the Claude Bernard Prize 2023

Congratulations to DiaUnion’s Samia Hamdan, who was the winner of the poster session at the Lund University Diabetes Centre LUDC Retreat. Her poster about the comparison between RBA… Read More »DiaUnion’s Samia Hamdan wins the poster session at the Lund University Diabetes Centre LUDC Retreat

Today Maria Sherman presented at the Lund University Diabetes Centre LUDC Retreat in Helsingborg. DiaUnion’s cross-border collaboration, which is instrumental for establishing an infrastructure for early detection… Read More »Maria Sherman presented at the Lund University Diabetes Centre LUDC Retreat in Helsingborg

Great morning at The Future of Swedish & Danish Life Science 2023! Strong interest in the DiaUnion screening program following start of screening for type… Read More »The Future of Swedish & Danish Life Science 2023

👉 “I have high expectations”, says professor, senior physician, MD. Flemming Pociot (pictured) about the screening program for type 1 diabetes, which has just started… Read More »As part of DiaUnion, Steno Diabetes Center is now starting screening for type 1 diabetes in Denmark

Great to share results from our screening program using multiplex assays at ADA. We are also here to discuss collaboration around screening for type 1… Read More »American Diabetes Association’s 83th Scientific Sessions

Read the full article here.

Antibody detection by agglutination-PCR (ADAP) assays for the analysis of tissue transglutaminase autoantibodies in celiac disease. Read the full article here.